default author photo

Cor van der Leest

Amphia Hospital

SCHOLARLY PAPERS

3

DOWNLOADS

211

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

High Dose Osimertinib in Patients with Advanced Stage EGFR Exon 20 Mutation-Positive NSCLC: Results from the Phase 2 Multicenter POSITION20 Trial

Number of pages: 21 Posted: 25 Feb 2022
Fenneke Zwierenga, Bianca van Veggel, Lizza E.L. Hendriks, T.Jeroen N. Hiltermann, Birgitta I. Hiddinga, Lucie B.M. Hijmering – Kappelle, Arja ter Elst, Sayed M.S. Hashemi, A-M.C. Dingemans, Cor van der Leest, Adrianus J. de Langen, Michel van den Heuvel and Anthonie J. van der Wekken
University of Groningen - Department of Pulmonology, affiliation not provided to SSRN, Maastricht University, University of Groningen - Department of Pulmonary Diseases, affiliation not provided to SSRN, University of Groningen - University Medical Center Groningen, affiliation not provided to SSRN, affiliation not provided to SSRN, Erasmus University Rotterdam, Amphia Hospital, Netherlands Cancer Institute, Radboud University Nijmegen - Department of Pulmonary Diseases and University of Groningen - University Medical Center Groningen
Downloads 89 (753,595)

Abstract:

Loading...

Non-small cell lung cancer, epidermal growth factor receptor, tyrosine kinase inhibitors, exon 20 mutation, Osimertinib

2.

The Clinical Benefit of Routine Comprehensive Genomic Profiling in Non-Small Cell Lung Cancer for the Detection of Prognostic Co-Mutations – a Multicenter Next Generation Sequencing Study

Number of pages: 28 Posted: 22 Jul 2025
Shaylin Aman Soekhoe, A-M.C. Dingemans, Folkert J. van Kemenade, Remigio W. Rouse, David C.Y. Yick, Cor van der Leest, Hendrikus Jan Dubbink and Jan von der Thüsen
affiliation not provided to SSRN, Erasmus University Rotterdam, Erasmus University Rotterdam (EUR) - Erasmus Medical Center (MC), Amphia Hospital, affiliation not provided to SSRN, Amphia Hospital, affiliation not provided to SSRN and Erasmus University Rotterdam (EUR) - Erasmus Medical Center (MC)
Downloads 69 (891,180)

Abstract:

Loading...

NSCLC, Co-mutations, Next-generation sequencing, Actionable genomic alterations, TP53, STK11, KEAP1

3.

Prophylactic folinic acid prevents pemetrexed myelosuppression: a randomized trial toward safer treatment with chemotherapy in non-small cell lung cancer

Number of pages: 21 Posted: 26 Nov 2025
Ramon Contrucci, Rob ter Heine, Merel Tonn, Jeroen Diepstraten, Eric van Thiel, Charlotte van Kesteren, Michel van den Heuvel, Cor van der Leest and Nikki de Rouw
affiliation not provided to SSRN, Radboud University Nijmegen - Department of Pharmacy and Radboud Center for Infectious Diseases, Amphia Hospital, Amphia Hospital, Albert Schweitzer Hospital, Albert Schweitzer Hospital, Radboud University Nijmegen - Department of Pulmonary Diseases, Amphia Hospital and Amphia Hospital
Downloads 53 (1,031,043)

Abstract:

Loading...

NSCLC, folinic acid, pemetrexed, myelosuppression, neutropenia, toxicity